These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 3151755)

  • 1. Toxic effects of nifurtimox and benznidazole, two drugs used against American trypanosomiasis (Chagas' disease).
    Castro JA; Diaz de Toranzo EG
    Biomed Environ Sci; 1988 Jun; 1(1):19-33. PubMed ID: 3151755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis).
    Castro JA; de Mecca MM; Bartel LC
    Hum Exp Toxicol; 2006 Aug; 25(8):471-9. PubMed ID: 16937919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural alterations in ovaries from nifurtimox or benznidazole-treated rats: their relation to ovarian nitroreductive biotransformation of both drugs.
    de Castro CR; de Toranzo EG; Bernacchi AS; Carbone M; Castro JA
    Exp Mol Pathol; 1989 Jun; 50(3):385-97. PubMed ID: 2721655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial.
    Villar JC; Herrera VM; Pérez Carreño JG; Váquiro Herrera E; Castellanos Domínguez YZ; Vásquez SM; Cucunubá ZM; Prado NG; Hernández Y
    Trials; 2019 Jul; 20(1):431. PubMed ID: 31307503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chagas' disease: clastogenic effect of nifurtimox and benznidazole in children].
    Moya PR; Trombotto GT
    Medicina (B Aires); 1988; 48(5):487-91. PubMed ID: 3151216
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination therapy using nitro compounds improves the efficacy of experimental Chagas disease treatment.
    Mazzeti AL; Gonçalves KR; Mota SLA; Pereira DE; Diniz LF; Bahia MT
    Parasitology; 2021 Sep; 148(11):1320-1327. PubMed ID: 34247670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term comparative pharmacovigilance of orally transmitted Chagas disease: first report.
    Alarcón de Noya B; Ruiz-Guevara R; Noya O; Castro J; Ossenkopp J; Díaz-Bello Z; Colmenares C; Suárez JA; Noya-Alarcón O; Naranjo L; Gutiérrez H; Quinci G; Torres J
    Expert Rev Anti Infect Ther; 2017 Mar; 15(3):319-325. PubMed ID: 28132566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver microsomal benznidazole and nifurtimox nitroreductase activity in male rats of different age.
    Aguilar E; de Arranz CK; de Toranzo EG; Castro JA
    Arch Int Pharmacodyn Ther; 1987 Sep; 289(1):11-7. PubMed ID: 3435199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental and Clinical Treatment of Chagas Disease: A Review.
    Sales Junior PA; Molina I; Fonseca Murta SM; Sánchez-Montalvá A; Salvador F; Corrêa-Oliveira R; Carneiro CM
    Am J Trop Med Hyg; 2017 Nov; 97(5):1289-1303. PubMed ID: 29016289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Possibility of treatment in Chagas' disease].
    Prata A
    AMB Rev Assoc Med Bras; 1978 Apr; 24(4):140-2. PubMed ID: 98813
    [No Abstract]   [Full Text] [Related]  

  • 11. Benznidazole biotransformation in rat heart microsomal fraction without observable ultrastructural alterations: comparison to Nifurtimox-induced cardiac effects.
    Mecca MM; Bartel LC; Castro CR; Castro JA
    Mem Inst Oswaldo Cruz; 2008 Sep; 103(6):549-53. PubMed ID: 18949324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species and sex differences in the liver microsomal nitroreductive biotransformation of nifurtimox and benznidazole.
    Aguilar EG; Koldobsky C; de Toranzo EG; Castro JA
    Arch Int Pharmacodyn Ther; 1987 Jun; 287(2):181-7. PubMed ID: 3632141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
    Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
    Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nifurtimox or benznidazole administration on rat testes: ultrastructural observations and biochemical studies.
    Bernacchi AS; de Castro CR; de Toranzo EG; Castro JA
    Exp Mol Pathol; 1986 Dec; 45(3):245-56. PubMed ID: 3792509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative controlled study on the use of benznidazole, nifurtimox and placebo, in the chronic form of Chagas' disease, in a field area with interrupted transmission. I. Preliminary evaluation].
    Coura JR; de Abreu LL; Willcox HP; Petana W
    Rev Soc Bras Med Trop; 1997; 30(2):139-44. PubMed ID: 9148337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment.
    Pérez-Molina JA; Sojo-Dorado J; Norman F; Monge-Maillo B; Díaz-Menéndez M; Albajar-Viñas P; López-Vélez R
    Acta Trop; 2013 Aug; 127(2):101-4. PubMed ID: 23583863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of Chagas' disease].
    Apt W
    Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147
    [No Abstract]   [Full Text] [Related]  

  • 18. Rat liver nuclear nifurtimox nitroreductase activity.
    de Toranzo EG; Herrera DM; Castro JA
    Res Commun Mol Pathol Pharmacol; 1997 Dec; 98(3):249-54. PubMed ID: 9485519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sister-chromatid exchange in spleenic lymphocytes of mice after exposure to nifurtimox or benznidazole.
    Gorla NB
    Mutat Res; 1987 Jun; 188(2):129-33. PubMed ID: 3587260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Current prospects of specific treatment of Chagas' disease].
    Coura JR
    Bol Chil Parasitol; 1996; 51(3-4):69-75. PubMed ID: 9302778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.